Current status and advances of immunotherapy in nasopharyngeal carcinoma.

Xu, Jian-Ying; Wei, Xiao-Li; Wang, Yi-Qin; Wang, Feng-Hua

Xu, Jian-Ying; Wei, Xiao-Li; Wang, Yi-Qin; Wang, Feng-Hua.

Afiliación

Xu JY; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
Wei XL; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
Wang YQ; Department of Clinical Medicine, Sun Yat-sen University, Guangzhou, P.R. China.
Wang FH; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dong Feng Road East, Guangzhou 510060, Guangdong, P.R. China.

Ther Adv Med Oncol ; 14: 17588359221096214, 2022.

Article en En | MEDLINE | ID: mdl-35547095

Palabras clave

Immune checkpoint inhibitors; immunotherapy; nasopharyngeal carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Año: 2022 Tipo del documento: Article